Source:http://linkedlifedata.com/resource/pubmed/id/19937732
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007587,
umls-concept:C0023418,
umls-concept:C0031671,
umls-concept:C0086418,
umls-concept:C0219474,
umls-concept:C0327441,
umls-concept:C0376515,
umls-concept:C0596138,
umls-concept:C0600432,
umls-concept:C1150587,
umls-concept:C1171362,
umls-concept:C1273518,
umls-concept:C1367731,
umls-concept:C1705632,
umls-concept:C1709059,
umls-concept:C1879547
|
pubmed:issue |
1
|
pubmed:dateCreated |
2009-12-28
|
pubmed:abstractText |
Phospholipase A(2) (PLA(2)) from Naja naja atra venom induced apoptotic death of human leukemia K562 cells. Degradation of procaspases, production of tBid, loss of mitochondrial membrane potential, Bcl-2 degradation, mitochondrial translocation of Bax, and cytochrome c release were observed in PLA(2)-treated cells. Moreover, PLA(2) treatment increased Fas and FasL protein expression. Upon exposure to PLA(2), activation of p38 MAPK (mitogen-activated protein kinase) and JNK (c-Jun NH(2)-terminal kinase) was found in K562 cells. SB202190 (p38 MAPK inhibitor) pretreatment enhanced cytotoxic effect of PLA(2) and led to prolonged JNK activation, but failed to affect PLA(2)-induced upregulation of Fas and FasL protein expression. Sustained JNK activation aggravated caspase8/mitochondria-dependent death pathway, downregulated Bcl-2 expression and increased mitochondrial translocation of Bax. SP600125 (JNK inhibitor) abolished the cytotoxic effect of PLA(2) and PLA(2)-induced autocrine Fas death pathway. Transfection ASK1 siRNA and overexpression of dominant negative p38alpha MAPK proved that ASK1 pathway was responsible for PLA(2)-induced p38 MAPK and JNK activation and p38alpha MAPK activation suppressed dynamically persistent JNK activation. Downregulation of FADD abolished PLA(2)-induced procaspase-8 degradation and rescued viability of PLA(2)-treated cells. Taken together, our results indicate that JNK-mediated autocrine Fas/FasL apoptotic mechanism and modulation of Bcl-2 family proteins are involved in PLA(2)-induced death of K562 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Cobra Venoms,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein,
http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 4,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1097-4644
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
109
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-54
|
pubmed:meshHeading |
pubmed-meshheading:19937732-Antigens, CD95,
pubmed-meshheading:19937732-Apoptosis,
pubmed-meshheading:19937732-Blotting, Western,
pubmed-meshheading:19937732-Cell Separation,
pubmed-meshheading:19937732-Cell Survival,
pubmed-meshheading:19937732-Cobra Venoms,
pubmed-meshheading:19937732-Enzyme Activation,
pubmed-meshheading:19937732-Enzyme Inhibitors,
pubmed-meshheading:19937732-Fas Ligand Protein,
pubmed-meshheading:19937732-Flow Cytometry,
pubmed-meshheading:19937732-Humans,
pubmed-meshheading:19937732-K562 Cells,
pubmed-meshheading:19937732-Leukemia,
pubmed-meshheading:19937732-MAP Kinase Kinase 4,
pubmed-meshheading:19937732-Membrane Potential, Mitochondrial,
pubmed-meshheading:19937732-Phospholipases A2,
pubmed-meshheading:19937732-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:19937732-RNA Interference,
pubmed-meshheading:19937732-Signal Transduction,
pubmed-meshheading:19937732-Transfection,
pubmed-meshheading:19937732-bcl-2-Associated X Protein
|
pubmed:year |
2010
|
pubmed:articleTitle |
Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells.
|
pubmed:affiliation |
Institute of Biomedical Sciences, National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|